XENOGEN CORPORATION FORM OF RESTRICTED STOCK PURCHASE AGREEMENTRestricted Stock Purchase Agreement • April 2nd, 2004 • Xenogen Corp • Services-commercial physical & biological research • California
This Restricted Stock Purchase Agreement (the “Agreement”) is made as of , 200 by and between Xenogen Corporation, a Delaware corporation (the “Company”), and (the “Purchaser”).
CONFIDENTIAL TREATMENT GRANTED. CERTAIN PORTIONS OF THIS AGREEMENT HAVE BEEN REDACTED AND SEPARATELY FILED WITH THE COMMISSION.] COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • April 2nd, 2004 • Xenogen Corp • Services-commercial physical & biological research • New Jersey
This COLLABORATIVE RESEARCH AGREEMENT (“Agreement”) is entered into as of December 28, 2000 by and between PFIZER INC, a Delaware corporation, having an office at 235 East 42nd Street, New York, New York 10017 and its Affiliates (“Pfizer”), and XENOGEN BIOSCIENCES (“Xenogen Cranbury”), an Ohio Corporation, with an office at 5 Cedar Brook Drive, Cranbury, NJ 08512, and a wholly owned subsidiary of Xenogen Corp. (“Xenogen”).
CONFIDENTIAL TREATMENT GRANTED. CERTAIN PORTIONS OF THIS AGREEMENT HAVE BEEN REDACTED AND SEPARATELY FILED WITH THE COMMISSION] COMMERCIAL LICENSE AGREEMENTCommercial License Agreement • April 2nd, 2004 • Xenogen Corp • Services-commercial physical & biological research • California
This Agreement (the “Agreement”) effective as of July 12, 2000 (the “Effective Date”) is made by and between Xenogen Corporation, having a principal place of business at 860 Atlantic Avenue, Alameda, California 94501 (“Xenogen”) and IRM, LLC, a Delaware Corporation, (“IRM”), having a principal place of business at Sofia House, 48 Church Street, Hamilton, Bermuda.
CONFIDENTIAL TREATMENT GRANTED. CERTAIN PORTIONS OF THIS AGREEMENT HAVE BEEN REDACTED AND SEPARATELY FILED WITH THE COMMISSION] LICENSE AGREEMENTLicense Agreement • April 2nd, 2004 • Xenogen Corp • Services-commercial physical & biological research • Ohio
This Agreement made this 13th day of June, 1985 between the Ohio University, a body politic incorporated under the laws of the State of Ohio having its principal office at Athens, Ohio 45701 (hereinafter “Licensor”), and Embryogen, Inc., a corporation under the laws of the State of Ohio having its principal office at One President Street, Athens, Ohio 45701 (hereinafter “licensee”).
CONFIDENTIAL TREATMENT GRANTED. CONFIDENTIAL PORTIONS OF THIS AGREEMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION.] AGREEMENTLicensing Agreement • April 2nd, 2004 • Xenogen Corp • Services-commercial physical & biological research • California
Effective as of May 5, 2000 (“Effective Date”), THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, a body having corporate powers under the laws of the State of California (“STANFORD”), and Xenogen Corporation, a California corporation, having a principal place of business at 860 Atlantic Avenue, Alameda, CA 94501 (“LICENSEE”), agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • April 2nd, 2004 • Xenogen Corp • Services-commercial physical & biological research • California
This Employment Agreement is entered into as of January 21, 1998 (the “Effective Date”), by and between XENOGEN CORPORATION, a California corporation (the “Company”), and PAMELA CONTAG (the “Employee”).
XENOGEN CORPORATION AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • April 2nd, 2004 • Xenogen Corp • Services-commercial physical & biological research • California
This Amended and Restated Investors’ Rights Agreement (the “Agreement”) is made as of July 8, 2003 by and among Xenogen Corporation, a Delaware corporation (the “Company”), and the individuals and entities listed on Exhibit A attached hereto (the “Investors”). This Agreement amends and restates the Amended and Restated Investors’ Rights Agreement dated as of April 30, 2003 (the “Prior Agreement”).
LEASE AGREEMENTLease Agreement • April 2nd, 2004 • Xenogen Corp • Services-commercial physical & biological research
THIS LEASE is executed this 22nd day of February, 2000, by and between DUKE-WEEKS REALTY LIMITED PARTNERSHIP, an Indiana limited partnership (“Landlord”), and INCYTE PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
AGREEMENT CEDAR BROOK CORPORATE CENTER, L P. AND CHRYSALIS DNX TRANSGENIC SCIENCE CORP.Lease Agreement • April 2nd, 2004 • Xenogen Corp • Services-commercial physical & biological research
AGREEMENT, made as of August , 1998, between CEDAR BROOK 11 CORPORATE CENTER, L.P., 1000 Eastpark Blvd., Cranbury, New Jersey 08512 “Landlord”; and CHRYSALIS DNX TRANSGENIC SCIENCE CORP., 301 College Road East, Princeton, New Jersey 08540, “Tenant”.
EMPLOYMENT AGREEMENTEmployment Agreement • April 2nd, 2004 • Xenogen Corp • Services-commercial physical & biological research • California
This Employment Agreement is entered into as of January 21, 1998 (the “Effective Date”), by and between XENOGEN CORPORATION, a California corporation (the “Company”), and DAVID CARTER (the “Employee”).
